Latest filing published 23 Nov 2020 for PhaseBio Pharmaceuticals Inc, €2,323.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David James Ballance: trading record in brief
All filings by David James Ballance on record concern PhaseBio Pharmaceuticals Inc. The record holds 2 filings, for trades running from 13 December 2018 to 20 November 2020.
The open-market record is one-sided, with 1 purchase worth €3,464 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant.
The latest filing, published on 23 November 2020, reports a share grant of €2,323 in PhaseBio Pharmaceuticals Inc. The most recent open-market purchase was published on 17 December 2018, 2,884 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David James Ballance
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 919 shares@ US$3.00100.0% of flowCommon StockSEC:0001169245-20-000100:0
- 1,000 shares@ US$3.9459.9% of flowCommon StockSEC:0001209191-18-062939:0Canonical exit: 13 Mar 2019 (T+90)
2 of 2 declarations